Search for: "Doe et al v. Johnson et al"
Results 421 - 440
of 452
Sorted by Relevance
|
Sort by Date
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
20 Jun 2023, 7:09 pm
But does all this drama signify anything? [read post]
11 Oct 2010, 9:48 pm
References Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, Bartleson CA, Lewis JH, Barrett TJ, Wells JG, et al., (1994). [read post]
1 Sep 2015, 7:22 pm
References Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, Bartleson CA, Lewis JH, Barrett TJ, Wells JG, et al., (1994). [read post]
13 Aug 2010, 2:41 pm
References Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, Bartleson CA, Lewis JH, Barrett TJ, Wells JG, et al., (1994). [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
26 Sep 2022, 6:00 am
Complaint ¶ 1, Alianza Americas v. [read post]
12 Jan 2017, 7:01 am
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
25 Sep 2024, 6:06 am
By Jessica Mellen Followers of art news are likely well aware of the headlining FBI raid of the Heroes and Monsters exhibit by the Orlando Museum of Art (OMA). [read post]
22 Jul 2024, 11:26 am
”[7] The Supreme Court’s 2019 decision in Fourth Estate v. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
6 Mar 2008, 12:19 pm
Olivier v. [read post]
29 May 2011, 9:30 am
On May 22, Walter Joseph Kowalski of Red Hook, New York passed away at age 88. [read post]
29 Nov 2011, 1:20 am
I mean really, how often does prior art have sex appeal? [read post]
19 Jun 2022, 4:44 pm
The Justices of that Court, however, would probably be the first to disclaim any credibility on the causes of any disease.[3] The authors further distort the notion of signature diseases by stating that “[v]aginal adenocarcinoma in young women appears to be a signature disease associated with maternal use of DES. [read post]
12 Apr 2019, 2:35 pm
Social Security And Taxes Many senior citizens preparing for retirement may not realize that their Social Security income could be taxable under certain conditions. [read post]
7 Jun 2010, 9:54 am
§9601 et seq. [read post]
7 Jun 2010, 10:04 am
§9601 et seq. [read post]
9 Apr 2022, 3:01 am
Karen Bass et al. [read post]
